Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production - PubMed (original) (raw)
Comparative Study
Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production
Roel H DeRijk et al. J Neuroimmunol. 2004 Jun.
Abstract
We assessed corticosteroid sensitivity in multiple sclerosis (MS) patients compared to control subjects, using an in vitro assay of dexamethasone (Dex) inhibition of lipopolysaccharide (LPS) stimulated-blood interleukin-6 production. Significantly higher concentrations of dexamethasone were needed to obtain 50%-inhibition (ID(50)) of in vitro LPS stimulated interleukin (IL)-6 production (28.4 x 10(-7) M) in relapsing-remitting MS (RRMS) patients compared to chronic progressive MS (CPMS) patients (6.2 x 10(-7) M) or compared to controls (3.0 x 10(-7) M). We also found a trend towards worsening of clinical status over time with increasing corticosteroid resistance. These data suggest that corticosteroid sensitivity may be a factor in the pathogenesis and could be used for prognosis of MS.
Similar articles
- IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis.
Frisullo G, Nociti V, Iorio R, Patanella AK, Marti A, Caggiula M, Mirabella M, Tonali PA, Batocchi AP. Frisullo G, et al. Cytokine. 2008 Oct;44(1):22-5. doi: 10.1016/j.cyto.2008.08.007. Epub 2008 Sep 14. Cytokine. 2008. PMID: 18793860 - Correlation between disease severity and in vitro cytokine production mediated by MSRV (multiple sclerosis associated retroviral element) envelope protein in patients with multiple sclerosis.
Rolland A, Jouvin-Marche E, Saresella M, Ferrante P, Cavaretta R, Créange A, Marche P, Perron H. Rolland A, et al. J Neuroimmunol. 2005 Mar;160(1-2):195-203. doi: 10.1016/j.jneuroim.2004.10.019. Epub 2004 Dec 8. J Neuroimmunol. 2005. PMID: 15710473 - Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K, Hellings N, Hensen K, Rummens JL, Medaer R, D'hooghe MB, Dubois B, Raus J, Stinissen P. Venken K, et al. J Neurosci Res. 2006 Jun;83(8):1432-46. doi: 10.1002/jnr.20852. J Neurosci Res. 2006. PMID: 16583400 - Management of worsening multiple sclerosis with mitoxantrone: a review.
Fox EJ. Fox EJ. Clin Ther. 2006 Apr;28(4):461-74. doi: 10.1016/j.clinthera.2006.04.013. Clin Ther. 2006. PMID: 16750460 Review. - [Immunomodulatory therapy in multiple sclerosis].
Csépány T, Bereczki D. Csépány T, et al. Ideggyogy Sz. 2004 Nov 20;57(11-12):401-16. Ideggyogy Sz. 2004. PMID: 15662768 Review. Hungarian.
Cited by
- Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis.
Morris G, Reiche EMV, Murru A, Carvalho AF, Maes M, Berk M, Puri BK. Morris G, et al. Mol Neurobiol. 2018 Aug;55(8):6282-6306. doi: 10.1007/s12035-017-0843-5. Epub 2018 Jan 2. Mol Neurobiol. 2018. PMID: 29294244 Free PMC article. Review. - Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis.
Weygandt M, Meyer-Arndt L, Behrens JR, Wakonig K, Bellmann-Strobl J, Ritter K, Scheel M, Brandt AU, Labadie C, Hetzer S, Gold SM, Paul F, Haynes JD. Weygandt M, et al. Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13444-13449. doi: 10.1073/pnas.1605829113. Epub 2016 Nov 7. Proc Natl Acad Sci U S A. 2016. PMID: 27821732 Free PMC article. - Stress and multiple sclerosis.
Mohr DC. Mohr DC. J Neurol. 2007 May;254 Suppl 2:II65-8. doi: 10.1007/s00415-007-2015-4. J Neurol. 2007. PMID: 17503132 Review. - Glucocorticoid sensitivity in health and disease.
Quax RA, Manenschijn L, Koper JW, Hazes JM, Lamberts SW, van Rossum EF, Feelders RA. Quax RA, et al. Nat Rev Endocrinol. 2013 Nov;9(11):670-86. doi: 10.1038/nrendo.2013.183. Epub 2013 Oct 1. Nat Rev Endocrinol. 2013. PMID: 24080732 Review. - Altered Coupling of Psychological Relaxation and Regional Volume of Brain Reward Areas in Multiple Sclerosis.
Wakonig K, Eitel F, Ritter K, Hetzer S, Schmitz-Hübsch T, Bellmann-Strobl J, Haynes JD, Brandt AU, Gold SM, Paul F, Weygandt M. Wakonig K, et al. Front Neurol. 2020 Oct 6;11:568850. doi: 10.3389/fneur.2020.568850. eCollection 2020. Front Neurol. 2020. PMID: 33117263 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical